首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   489篇
  免费   14篇
  国内免费   26篇
医药卫生   529篇
  2021年   9篇
  2020年   5篇
  2019年   12篇
  2018年   9篇
  2017年   2篇
  2016年   7篇
  2015年   10篇
  2014年   10篇
  2013年   10篇
  2012年   12篇
  2011年   17篇
  2010年   15篇
  2009年   22篇
  2008年   16篇
  2007年   21篇
  2006年   43篇
  2005年   22篇
  2004年   15篇
  2003年   8篇
  2002年   5篇
  2001年   9篇
  2000年   9篇
  1999年   8篇
  1998年   14篇
  1997年   7篇
  1996年   22篇
  1995年   15篇
  1994年   16篇
  1993年   7篇
  1992年   9篇
  1991年   9篇
  1990年   9篇
  1989年   16篇
  1988年   15篇
  1987年   14篇
  1986年   12篇
  1985年   16篇
  1984年   4篇
  1983年   6篇
  1982年   3篇
  1981年   8篇
  1980年   6篇
  1979年   2篇
  1978年   2篇
  1977年   4篇
  1976年   2篇
  1975年   3篇
  1955年   2篇
  1954年   2篇
  1943年   2篇
排序方式: 共有529条查询结果,搜索用时 250 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
9.
Paramagnetic macrocyclic chelates show promise as magnetic resonance (MR) imaging contrast agents due to stability and relaxivity comparable to those of DTPA-type chelates. For the three copper and manganese macrocyclic complexes studied in aqueous solution, T1 and T2 relaxivities ranged from 0.14 to 5.88 mM-1sec-1 at 6.25 MHz. In rats, the intravenous administration of 16 mumol/kg of Mn(cyclam) caused the liver T1 relaxation rate to double at 15 minutes after injection. T1 measurements by pulsed MR imaging and manganese analyses on excised tissue showed that both relaxation rate (1/T1) and manganese content of liver and kidney increase linearly with the dosage of Mn(cyclam). The linear relationship between 1/T1 and manganese content can be considered an "in tissue" relaxivity plot for the agent. The resulting relaxivity is 54 mM-1sec-1 in liver, compared with 3.1 mM-1sec-1 in aqueous solution. Although this work is preliminary, the implication for medical MR imaging applications is that macrocyclic contrast agents can be effective at approximately one-tenth the current typical dose used for gadolinium DTPA.  相似文献   
10.

Objectives

The combination of abdominal aortic aneurysm repair with other intra-abdominal surgery is controversial. Most studies have shown that a variety of procedures can be performed at the same time as an aneurysm repair with little change in mortality or complication rates. We conducted a retrospective study to determine if aneurysm repair could be safely and effectively combined with radical nephrectomy.

Methods

We studied 10 patients who underwent combined abdominal aortic aneurysm repair and radical nephrectomy during a 4-year period. Results from this group were compared to a separate control group of 10 patients who underwent radical nephrectomy alone and another of 12 patients who underwent abdominal aortic aneurysm repair alone, during the same time period.

Results

The overall mortality was 10% and significant complications occurred in an additional 10% of patients. Minor, self-limiting complications occurred in 30% of patients. There were no aortic graft infections that occurred in the entire series of patients at 18 months of mean follow-up. There were no remarkable differences in length of stay, age, operating time, blood loss, morbidity, and mortality between this series of patients and the combined values in a separate group of control patients who had undergone either procedure alone.

Conclusions

Simultaneous radical nephrectomy for presumed renal cell carcinoma can be safely combined with repair of abdominal aortic aneurysm in selected patients.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号